VRTX | Vertex Pharmaceuticals Incorporated Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)

*Sign In to persist settings

Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31
Revenue	9.84B	8.93B	7.57B	6.21B	4.16B	3.05B	2.49B	1.70B	1.03B	580.41M	1.21B	1.53B	1.41B	143.37M	101.89M	175.50M	199.01M	216.36M	160.89M	102.72M	69.14M	161.09M	167.49M	78.13M	61.60M	44.40M	43.80M	13.30M	22.10M	19.60M
Cost of Revenue	1.26B	1.08B	904.20M	736.30M	547.76M	409.54M	275.12M	210.46M	124.51M	60.99M	130.28M	279.88M	80.50M	12.73M	14.20M	15.69M	13.90M	12.17M	10.10M	5.65M	3.13M	28.28M	39.63M	4.08M	-3.40M	-4.50M	-3.60M	-3.20M	-3.70M	-3.50M
Gross Profit	8.58B	7.85B	6.67B	5.47B	3.62B	2.64B	2.21B	1.49B	907.82M	519.43M	1.08B	1.25B	1.33B	130.64M	87.69M	159.82M	185.11M	204.19M	150.79M	97.07M	66.02M	132.80M	127.86M	74.05M	65.00M	48.90M	47.40M	16.50M	25.80M	23.10M
Operating Expenses	4.83B	3.48B	3.89B	2.60B	2.41B	1.97B	1.82B	1.48B	1.37B	1.16B	1.28B	1.24B	1.11B	825.22M	680.47M	618.20M	597.78M	429.57M	292.53M	234.30M	238.72M	252.41M	196.01M	112.73M	104.60M	81.30M	66.60M	46.30M	52.30M	43.80M
Selling, General & Admin	1.14B	944.70M	840.10M	770.46M	658.50M	557.62M	496.08M	432.83M	376.57M	305.41M	362.34M	436.80M	400.72M	187.80M	130.19M	101.91M	84.73M	57.86M	43.99M	42.14M	39.08M	49.39M	47.34M	27.81M	26.10M	18.10M	11.40M	7.90M	7.10M	40.30M
Research & Development	3.69B	2.54B	3.05B	1.83B	1.75B	1.42B	1.32B	1.05B	995.92M	855.51M	918.78M	806.18M	707.71M	637.42M	550.27M	516.29M	513.05M	371.71M	248.54M	192.16M	199.64M	203.02M	148.67M	84.92M	72.20M	58.70M	51.60M	35.20M	41.50M	N/A
Other Operating Expenses	-22.80M	-164.80M	4.90M	296.42M	192.18M	-790.00K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	6.30M	4.50M	3.60M	3.20M	3.70M	3.50M
Operating Income	3.75B	4.31B	2.78B	2.86B	1.20B	635.15M	123.24M	11.20M	-464.67M	-641.49M	-199.43M	4.18M	221.69M	-694.58M	-592.78M	-458.38M	-412.67M	-225.39M	-141.74M	-137.23M	-172.70M	-119.60M	-68.15M	-38.68M	-39.60M	-32.40M	-19.20M	-29.80M	-26.50M	-20.70M
Other Expenses / Income	629.60M	-75.00M	-51.70M	260.51M	197.35M	-29.61M	-138.93M	-78.56M	-93.13M	-93.39M	-776.69M	-16.56M	-161.25M	-60.05M	-41.22M	-4.32M	-7.12M	2.38M	-23.52M	-3.70M	-82.82M	-55.00K	-26.09M	-14.93M	-700.00K	N/A	N/A	-9.70M	5.50M	3.60M
Before Tax Income	4.38B	4.23B	2.73B	3.12B	1.39B	600.24M	-15.69M	-67.37M	-557.80M	-734.88M	-976.12M	-12.38M	60.45M	-754.63M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax Expenses	760.20M	910.40M	388.30M	405.15M	218.11M	-1.49B	-107.32M	16.66M	30.38M	6.96M	-288.57M	38.75M	19.27M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	3.62B	3.32B	2.34B	2.71B	1.18B	2.10B	263.48M	-112.05M	-556.33M	-738.55M	-445.03M	-107.03M	29.57M	-754.63M	-642.18M	-459.85M	-391.28M	-206.89M	-203.42M	-166.25M	-196.77M	-108.62M	-66.23M	-39.66M	-41.00M	-33.10M	-19.80M	-40.00M	-21.50M	-17.60M
Interest Expenses	44.10M	54.80M	61.50M	58.15M	58.50M	34.12M	57.55M	81.43M	84.21M	72.86M	22.73M	16.65M	38.45M	19.27M	13.19M	13.47M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Basic Shares Outstanding	257.70M	256.10M	257.70M	259.84M	256.73M	254.29M	248.86M	244.69M	241.31M	235.31M	224.91M	211.95M	204.89M	200.40M	173.26M	140.56M	128.99M	113.22M	89.24M	78.57M	77.00M	75.75M	74.46M	54.32M	51.04M	50.60M	48.53M	37.60M	34.13M	31.43M
Diluted Shares Outstanding	260.50M	259.10M	259.90M	263.40M	260.67M	259.19M	253.22M	244.69M	241.31M	235.31M	224.91M	211.95M	208.81M	200.40M	173.26M	140.56M	128.99M	113.22M	89.24M	78.57M	77.00M	75.75M	74.46M	54.32M	51.04M	50.60M	48.53M	37.60M	34.13M	31.43M
EBITDA	3.93B	4.35B	2.79B	3.19B	1.46B	663.18M	275.11M	47.44M	-379.40M	-595.48M	-662.50M	-13.43M	122.33M	-704.89M	-598.88M	-414.18M	-363.82M	-181.02M	-176.13M	-136.61M	-173.33M	-83.19M	-48.27M	-30.56M	-34.70M	-28.60M	-16.20M	-36.80M	-17.80M	-14.10M
EBITDA Margin	39.96%	48.65%	36.82%	51.37%	35.02%	21.76%	11.05%	2.79%	-36.75%	-102.60%	-54.66%	-0.88%	8.67%	-491.66%	-587.78%	-236.00%	-182.81%	-83.67%	-109.47%	-132.99%	-250.69%	-51.64%	-28.82%	-39.12%	-56.33%	-64.41%	-36.99%	-276.69%	-80.54%	-71.94%
EBIT	4.42B	4.29B	2.79B	3.18B	1.45B	644.15M	213.71M	-13.96M	-441.75M	-658.73M	-710.87M	-51.62M	87.29M	-735.35M	-628.99M	-446.38M	-391.28M	-206.89M	-203.42M	-166.25M	-196.77M	-108.62M	-66.23M	-39.66M	-41.00M	-33.10M	-19.80M	-40.00M	-21.50M	-17.60M
EBIT Margin	44.96%	48.01%	36.86%	51.16%	34.91%	21.14%	8.59%	-0.82%	-42.79%	-113.49%	-58.65%	-3.38%	6.19%	-512.90%	-617.32%	-254.34%	-196.61%	-95.63%	-126.43%	-161.85%	-284.59%	-67.43%	-39.54%	-50.76%	-66.56%	-74.55%	-45.21%	-300.75%	-97.29%	-89.80%
Financial Year End	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31	2005-12-31	2004-12-31	2003-12-31	2002-12-31	2001-12-31	2000-12-31	1999-12-31	1998-12-31	1997-12-31	1996-12-31	1995-12-31	1994-12-31